Skip to main content

ATP5SL Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-82703

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-82703-0.1ml

Key Product Details

Species Reactivity

Validated:

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Summary for ATP5SL Antibody

Immunogen

The immunogen is a synthetic peptide directed towards the C-terminal region of Human ATP5SL. Peptide sequence: ISDLPAVSNPGLTQILVEEMLPNCEVVGVDWAEGLKSGPEEQPRDTASPV The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for ATP5SL Antibody

Western Blot: ATP5SL Antibody [NBP2-82703]

Western Blot: ATP5SL Antibody [NBP2-82703]

Western Blot: ATP5SL Antibody [NBP2-82703] - Host: Rabbit. Target Name: ATP5SL. Sample Type: Jurkat Whole Cell lysates. Antibody Dilution: 1.0ug/ml

Applications for ATP5SL Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: ATP5SL

Alternate Names

ATP5SL ATP5S-like

Gene Symbol

ATP5SL

Additional ATP5SL Products

Product Documents for ATP5SL Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for ATP5SL Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...